Whiz
Acquired5 known investors
A platform providing analytics, insights, and reporting that lets organizations access, process, and distribute large volumes of data and turn it into personalized, actionable views governed by consistent business rules. The page presents an IQVIA Analytics, Insights & Reporting (AIR) product.
Also known as Whiz.ai · Whiz.ai Inc · WhizAI · Whizdotai, Inc.
Investors · 5
Company profile
researched Aug 2026Whiz (WhizAI, legally Whizdotai, Inc.) develops a conversational analytics platform that lets business users query enterprise data in natural language by voice or text on web and mobile. The platform is described as purpose-built for life sciences, pre-trained on life sciences data sources including 867 data, IQVIA data, CTMS and APLD, and on industry business terminology such as NRx, TRx, PBMs, plans and therapeutic areas, so that it can answer complex questions across billions of records in seconds. Responses are returned in whichever format best fits the request, including text, tables, graphs and reports, and users can ask follow-on questions because the system retains conversational context, switch data sources, reset context, and pin visualizations to build ad-hoc dashboards.
The company's domain now presents IQVIA's Analytics, Insights & Reporting (AIR) offering and refers to "WhizAI, an IQVIA business." In that context, WhizAI is positioned as GenAI-powered conversational analytics built on proprietary intent-ready natural language processing and a domain-tuned large language model, sitting alongside IQVIA's persona-based business intelligence reporting, IQ20/20 reporting solutions (including the Flexview tool), health equity insights reporting, and strategic advisory services for life sciences, MedTech and healthcare organizations. The wider AIR offering is described as BI-platform agnostic, working with IQ20/20, Tableau, Power BI, Qlik and ThoughtSpot, and includes AI/ML, natural language processing, tokenized de-identification and privacy tooling.
Founding story
Co-founder and CEO Rohit Vashisht, an engineer by training who began his software career in 2000 building business intelligence products, started the company in 2017 with a co-founder he had met roughly twenty years earlier while both worked on an early business intelligence product. Vashisht had previously founded a company in India in 1999, a fintech startup in 2007-2008, and the influencer marketing marketplace Sverve, which was acquired by Bloglovin and rebranded as Activate.
Business model
Enterprise software sold to life sciences organizations, with a browser-based application and a companion mobile client; in production, customers receive customized access to their own enterprise data sets rather than the publicly available sample data. Under IQVIA, the capability is offered as part of a broader portfolio spanning modular products, end-to-end implementations and consulting services.
Traction
Reported outcomes at enterprise pharmaceutical implementations include full adoption among business users and reductions in IT call volume and operational overhead within the first months of deployment. The Android mobile client, published by Whiz.ai Inc, has recorded more than 500 downloads and was last updated in September 2024.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
Positioned as a purpose-built life sciences conversational/augmented analytics platform used by large global life sciences companies, and cited as an IQVIA business in Gartner's Market Guide for Agentic Analytics.
Domain specialization is the stated differentiator: pre-training on life sciences data structures and terminology, intent-ready NLP paired with a domain-tuned LLM, sub-second to seconds response times over very large data volumes, and delivery of answers to non-technical field and commercial users through voice and text rather than dashboards.
Technology
Conversational, pre-trained AI for business analytics: proprietary intent-ready natural language processing and a domain-tuned large language model, with models trained on life sciences data sets (867, IQVIA, CTMS, APLD) and life sciences business terminology. The system maintains query context across follow-on questions, selects an appropriate output format (text, table, chart, report), and is described as answering questions over billions of records in seconds, largely in milliseconds.
Go-to-market
Life sciences and pharmaceutical enterprises, including commercial field users, sales representatives and brand teams; the surrounding IQVIA portfolio also addresses MedTech and healthcare organizations.
Geography
United States; the developer address listed for the mobile app is 220 Davidson Ave Ste 105, Somerset, New Jersey, and the CEO is described as based in New Jersey. The IQVIA AIR page is a United States solutions page.
History
The company was started in 2017 as a conversational analytics platform for life sciences. It subsequently became part of IQVIA, and its former domain now hosts IQVIA's Analytics, Insights & Reporting materials, which describe WhizAI as an IQVIA business.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 1
launches, deals, and filingsThe whiz.ai site presents IQVIA's Analytics, Insights & Reporting offering and describes WhizAI as "an IQVIA business" providing GenAI-powered conversational analytics.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Whizwhiz.ai · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Whiz do?
- WhizAI is a natural-language analytics platform for life sciences data, now operating as an IQVIA business.
- Who are Whiz's investors?
- Whiz's investors include Bling Capital, Cerity Partners Ventures, Healthy Ventures, Summit Peak Ventures, Vertical Venture Partners.

